同时与延迟切除治疗初始可切除结直肠癌肝转移的前瞻性随机对照试验
该前瞻性开放标签随机对照试验纳入105例结直肠癌伴初始可切除同时性肝转移患者,比较同时切除与延迟切除转移灶。延迟切除组有8例未到达肝切除阶段,其中6例因疾病进展。中位随访47个月,同时切除组总生存有改善趋势(P=0.05)。
要点
- 同时切除与延迟切除的严重并发症率无显著差异(49% vs 46%,P=0.70)。
- 延迟切除组8例未行肝切除,6例因疾病进展。
- 同时切除组总生存有改善趋势(P=0.05,中位随访47个月)。
核心结论
- 同时切除结直肠癌原发灶与同时性肝转移灶的并发症率与延迟切除无显著差异。
- 延迟切除有损害总生存的趋势。
研究设计与样本
- 前瞻性、开放标签、随机对照试验。
- 纳入105例成人结直肠癌伴可切除同时性肝转移患者,随机分配至同时切除组或延迟切除组。
- 主要终点为术后60天内严重并发症发生率。
主要发现
- 严重围手术期并发症发生率同时切除组49%、延迟切除组46%(调整OR 0.84,95%CI 0.35-2.01;P=0.70)。
- 结直肠部位并发症率同时切除组28%、延迟切除组13%(P=0.08)。
- 肝脏部位并发症率同时切除组15%、延迟切除组17%(P=0.80)。
- 延迟切除组8例未到达肝切除阶段,其中6例因疾病进展。
- 2年总生存和无病生存同时切除组有改善趋势(P=0.05),中位随访47个月后总生存趋势持续。
关键数值与推荐
- 主要终点严重并发症:同时切除组49% vs 延迟切除组46%,调整OR 0.84(95%CI 0.35-2.01),P=0.70。
- 结直肠部位并发症:28% vs 13%,P=0.08。
- 肝脏部位并发症:15% vs 17%,P=0.80。
- 生存分析:2年总生存和无病生存同时切除组有改善趋势,P=0.05。
临床怎么用
- 对于初始可切除的同时性结直肠癌肝转移,同时切除策略的严重并发症风险与延迟切除相当。
- 延迟切除可能因疾病进展导致部分患者失去肝切除机会,需权衡生存获益。
局限性
- 开放标签设计可能引入偏倚。
- 总生存差异仅为趋势性(P=0.05),未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To answer whether synchronous colorectal cancer liver metastases (SLM) should be resected simultaneously with primary cancer or should be delayed. SUMMARY BACKGROUND DATA: Numerous studies have compared both strategies. All were retrospective and conclusions were contradictory. METHODS: Adults with colorectal cancer and resectable SLM were randomly assigned to either simultaneous or delayed resection of the metastases. The primary outcome was the rate of major complications within 60 days following surgery. Secondary outcomes included overall and disease-free survival. RESULTS: A total of 105 patients were recruited. Eighty-five patients (39 and 46 in the simultaneous- and delayed-resection groups, respectively) were analyzed. The percentage of major perioperative complications did not differ between groups (49% and 46% in the simultaneous- and delayed-resection groups, respectively, adjusted OR 0.84, 95% CI 0.35-2.01; P = 0.70, logistic regression). Complications rates were 28% and 13% (P = 0.08, χ2 test) at colorectal site and 15% and 17% (P = 0.80, χ2 test) at liver site, in simultaneous- and delayed-resection groups, respectively. In the delayed-resection group, 8 patients did not reach the liver resection stage, and this was due to disease progression in 6 cases. After 2 years, overall and disease-free survival tended to be improved in simultaneous as compared with delayed-resection groups (P = 0.05), a tendency which persisted for OS after a median follow-up of 47 months. CONCLUSIONS: Complication rates did not appear to differ when colorectal cancer and synchronous liver metastases are resected simultaneously. Delayed resection tended to impair overall survival.
引用
- Boudjema K, Locher C, Sabbagh C, et al. Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial. Ann Surg. 2021. PMID: 32209911. doi:10.1097/SLA.0000000000003848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。